IP Library Granted Patent US 8,762,065
Granted Patent B2
US 8,762,065 · App. 11/159,842 · Granted Jun 24, 2014

Closed-loop feedback-driven neuromodulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,762,065
App. No.
11/159,842
Granted
Jun 24, 2014
Kind
B2
Abstract

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators, comprising intracranial (IC) stimulating electrodes and other actuators, in accordance with treatment parameters. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

Claims (44)

1. A method of treating a patient's neurological or psychiatric disorder, the method comprising:

using a control module coupled to a first electrode and a second electrode to deliver electrical stimulation to a nervous system component through the first electrode and the second electrode to treat the patient's neurological or psychiatric disorder, said first electrode and said second electrode being implanted in the patient's body;

monitoring impedance between the first electrode and the second electrode;

automatically adjusting at least one parameter of the electrical stimulation to compensate for a monitored change of electrode impedance between the first electrode and the second electrode; and

delivering a subsequent electrical stimulation with the at least one adjusted parameter to the nervous system component through the first electrode and the second electrode to treat the patient's neurological or psychiatric disorder.

2. The method of claim 1 , further comprising providing an output to at least one of the patient and a health care provider of the monitored electrode impedance.

3. The method of claim 1 , further comprising storing an impedance history information in the control module.

4. The method of claim 2 , wherein the control module is implanted in the patient's body, and further comprising:

wirelessly transmitting a signal that is representative of the impedance history information from the implanted control module to a device that is external to the patient's body; and

providing an output from the external to at least one of the patient and a health care provider that is representative of the impedance history information.

5. The method of claim 1 , wherein the first electrode and second electrode are intracranial electrodes that are in direct communication with a patient's brain, wherein the electrical stimulation is delivered to the patient's brain to manage seizures.

6. The method of claim 1 , wherein the control module is adapted to monitor EEG signals from the patient and process the EEG signals to predict future symptomatology of the patient.

7. The method of claim 6 , wherein the neurological disorder comprises epilepsy and the future symptomatology comprises future seizures.

8. The method of claim 6 , wherein the electrical stimulation is delivered to the patient after the prediction of the future symptomatology.

9. The method of claim 6 , wherein parameters of the electrical stimulation are based at least on part on the predicted future symptomatology.

10. The method of claim 1 , wherein the nervous system component comprises a peripheral nerve, and wherein the first electrode and second electrode are adapted to be coupled to the peripheral nerve and the electrical stimulation is delivered to the patient's peripheral nerve to manage seizures.

11. The method of claim 10 , wherein the peripheral nerve comprises a vagus nerve.

12. The method of claim 1 , wherein the nervous system component comprises a peripheral nerve, wherein the first electrode and the second electrode are adapted to be coupled to the peripheral nerve and the electrical stimulation is delivered to the patient's peripheral nerve to manage depression.

13. The method of claim 1 , wherein the electrical stimulation comprises a current stimulation comprising known current parameters, wherein monitoring impedance between the first electrode and second electrode comprises:

measuring a voltage across the first electrode and second electrode; and

calculating the impedance across the first electrode and second electrode based on the known current parameters and the measured voltage.

14. The method of claim 1 wherein the electrical stimulation comprises charge-balanced biphasic waveforms.

15. A method of treating a patient's neurological or psychiatric disorder, the method comprising:

using a control module coupled to a first electrode and a second electrode to deliver electrical stimulation to a nervous system component through the first electrode and the second electrode to treat the patient's neurological or psychiatric disorder, said first electrode and said second electrode being implanted in the patient's body;

monitoring for a change of impedance between the first electrode and the second electrode;

automatically adjusting at least one parameter of the electrical stimulation to compensate for the change of impedance between the first electrode and the second electrode; and

delivering a subsequent electrical stimulation with the at least one adjusted parameter to the nervous system component through the first electrode and the second electrode to treat the patient's neurological or psychiatric disorder.

16. The method of claim 15 further comprising providing an output to at least one of the patient and a health care provider that is indicative of the change to the impedance between the first electrode and the second electrode.

17. The method of claim 15 further comprising storing an impedance history information in the control module.

18. The method of claim 17 wherein the control module is implanted in the patient's body, and further comprising:

wirelessly transmitting a signal that is representative of at least one of the impedance change and the impedance history information from the implanted control module to a device that is external to the patient's body; and

providing an output from the external to at least one of the patient and a health care provider that is representative of at least one of the impedance change and the impedance history information.

19. The method of claim 15 wherein the first electrode and the second electrode are intracranial electrodes that are in direct communication with a patient's brain, wherein the electrical stimulation is delivered to the patient's brain to manage seizures.

20. The method of claim 15 wherein the control module is adapted to monitor EEG signals from the patient and process the EEG signals to predict future symptomatology of the patient.

21. The method of claim 20 wherein the neurological disorder comprises epilepsy and the future symptomatology comprises future seizures.

22. The method of claim 20 wherein the electrical stimulation is delivered to the patient after the prediction of the future symptomatology.

23. The method of claim 20 wherein parameters of the electrical stimulation are based at least on part on the predicted future symptomatology.

24. The method of claim 15 wherein the nervous system component comprises a peripheral nerve, and wherein the first electrode and the second electrode are adapted to be coupled to the peripheral nerve and the electrical stimulation is delivered to the patient's peripheral nerve to manage seizures.

25. The method of claim 24 wherein the peripheral nerve comprises a vagus nerve.

26. The method of claim 15 wherein the nervous system component comprises a peripheral nerve, wherein the first electrode and the second electrode are adapted to be coupled to the peripheral nerve and the electrical stimulation is delivered to the patient's peripheral nerve to manage depression.

27. The method of claim 15 wherein the electrical stimulation comprises a current stimulation comprising known current parameters, wherein monitoring impedance between the first electrode and the second electrode comprises:

measuring a voltage across the first electrode and the second electrode; and

calculating the impedance across the first electrode and the second electrode based on the known current parameters and the measured voltage.

28. The method of claim 15 wherein the electrical stimulation comprises charge-balanced biphasic waveforms.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Oct 30, 2024
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: LIVANOVA USA, INC.
Reel/Frame 069072/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2024
From: LIVANOVA INC.; LIVANOVA USA INC.
To: DILORENZO BIOMEDICAL, LLC
Reel/Frame 067508/0068 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
CHANGE OF NAME Recorded Jun 29, 2020
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 053306/0229 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2013
From: NEUROVISTA CORPORATION
To: CYBERONICS, INC.
Reel/Frame 030192/0408 →
SECURITY AGREEMENT Recorded Sep 14, 2012
From: NEUROVISTA CORPORATION
To: CYBERONICS, INC.
Reel/Frame 028959/0395 →
CHANGE OF NAME Recorded Jun 5, 2007
From: BIONEURONICS CORPORATION
To: NEUROVISTA CORPORATION
Reel/Frame 019385/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2005
From: DILORENZO, DANIEL JOHN
To: BIONEURONICS CORPORATION
Reel/Frame 016611/0427 →